文献速递前列腺增生与排尿功能障碍

新型前列腺体积计算器助力日常泌尿科诊疗

A Novel Calculator for Estimating Prostate Volume in Daily Urology Services.
PubMed 文献 · Urology · 2018-05-07

该横断面研究纳入1034名40岁以上、无前列腺癌或前列腺手术史且未用5α还原酶抑制剂的多种族亚洲男性,用回归分析构建以前列腺特异性抗原(PSA)、年龄、体重、国际前列腺症状评分(IPSS)等为变量的前列腺体积(PV)计算器,并在197例验证集中验证。计算器预测PV>30 mL和>40 mL的曲线下面积分别为0.82和0.91。

要点

  • 计算器纳入年龄、IPSS、体重、α受体阻滞剂治疗史和PSA,公式简单易用。
  • 验证集预测PV>30 mL的AUC为0.82,预测PV>40 mL的AUC为0.91。
  • 该工具适用于日常门诊评估下尿路症状(LUTS)患者,但需在其他人群中验证。

核心结论

  • 研究开发了一个简单且准确的前列腺体积计算器,可用于LUTS患者的常规临床咨询。
  • 需开展单独研究在其他人群中确认和验证该结果。

研究设计与样本

  • 横断面研究,纳入1034名40岁以上、无前列腺癌史、无前列腺手术史且未接受5α还原酶抑制剂治疗的多种族亚洲男性。
  • 其中837名用于回归分析构建PV计算器,其余1/5(n=197)用于模型验证。

主要发现

  • 人群平均年龄60±7.6岁,平均PV为29.4±13.0 mL,PSA总体均值为1.7±1.7 ng/mL。
  • 回归模型中年龄、IPSS、体重和PSA均有统计学意义(均P<.05)。
  • 验证集中计算器的决定系数(R2)为0.47。
  • 计算器预测PV>30 mL的AUC为0.82(95%CI 0.75-0.88),预测PV>40 mL的AUC为0.91(95%CI 0.87-0.96)。

关键数值与推荐

  • PV计算公式:PV=20.6+(年龄-60)×0.1+(IPSS评分)×0.1+(体重-70)×0.3+(因LUTS接受α受体阻滞剂治疗史)×9.6+PSA×3.7。
  • 预测PV>30 mL的AUC为0.82(95%CI 0.75-0.88)。
  • 预测PV>40 mL的AUC为0.91(95%CI 0.87-0.96)。
  • 验证集决定系数R2为0.47。

临床怎么用

  • 可在日常泌尿科门诊用年龄、IPSS、体重、α受体阻滞剂治疗史和PSA快速估算PV,辅助LUTS患者管理。
  • 计算器简单易行,适合在发展中国家的常规临床咨询中使用。
  • 使用前需注意该模型尚未在其他人群中验证。

局限性

  • 研究为横断面设计,需单独研究在其他人群中确认和验证。
  • 验证集决定系数R2为0.47,模型解释力有限。
  • 研究对象为多种族亚洲男性,外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To develop a simple prostate volume (PV) calculator that can aid in managing patients with lower urinary tract symptoms (LUTS) secondary to benign prostatic enlargement at daily urology services in developing Asian countries. MATERIALS AND METHODS: We conducted a cross-sectional study of men aged above 40 years with no history of prostate cancer, prostate surgery, or 5α-reductase inhibitor treatment. Serum prostate-specific antigen (PSA) and total PV were measured in each subject. Potential sociodemographic and clinical variables including age, weight, comorbidities, and International Prostate Symptom Score (IPSS) were collected. Of 1034 subjects, 837 were used in building the PV calculator using regression analysis. The remaining 1/5 (n = 197) was used for model validation. RESULTS: There were 1034 multiethnic Asian men (Chinese 52.9%, Malay 35.4%, and Indian 11.7%) with mean age of 60 ± 7.6 years. Average PV was 29.4 ± 13.0 mL while the overall mean of PSA was 1.7 ± 1.7 ng/mL. We identified age, IPSS, weight, and PSA (all P <.05) in the PV regression model. Using the validation set, the coefficient of determination (R2) of this PV calculator was 0.47 where PV = 20.6 + (age - 60) × 0.1 + (IPSS score) × 0.1 + (Weight - 70) × 0.3 + (history of alpha-blocker treatment for LUTS) × 9.6 + PSA × 3.7. The area under curve of this model in predicting PV above 30 mL and 40 mL were 0.82 (95% confidence interval, 0.75-0.88) and 0.91 (95% confidence interval, 0.87-0.96), respectively. CONCLUSION: We develop a PV calculator that is simple and accurate to be used in routine clinical consultation for patients with LUTS. A separate study is important to confirm and to validate the findings in other populations.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Lim J, Rampal S, Razack AHA, et al. A Novel Calculator for Estimating Prostate Volume in Daily Urology Services. Urology. 2018. PMID: 29746873. doi:10.1016/j.urology.2018.02.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。